Targeted Swedish HFE (haemochromatosis) screening is a possibility
This article was originally published in Clinica
Executive Summary
Screening for hereditary haemochromatosis could be introduced for a pre-defined target group, but it would be unwise to introduce general screening for the disease, says a new report from the Swedish council on technology assessment in healthcare (SBU). SBU believes that, although genetic screening would help to identify patients most at risk, it is uncertain as to how many of these would actually contract the disease and therefore require clinical treatment.